Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism.
about
Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases.Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality.The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study.The Rotterdam Study: 2016 objectives and design update.Metabolomics, Lipidomics and Pharmacometabolomics of Human Hypertension.Metabolomic profiling to dissect the role of visceral fat in cardiometabolic healthConnecting genetic risk to disease end points through the human blood plasma proteomeImproving Visualization and Interpretation of Metabolome-Wide Association Studies: An Application in a Population-Based Cohort Using Untargeted 1H NMR Metabolic Profiling.Metabolome alterations in severe critical illness and vitamin D status.Mass spectrometry in epidemiological studies: What are the key considerations?Key elements of metabolomics in the study of biomarkers of diabetes.The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.The acute impact of polyphenols from Hibiscus sabdariffa in metabolic homeostasis: an approach combining metabolomics and gene-expression analyses.Metabolites of milk intake: a metabolomic approach in UK twins with findings replicated in two European cohorts.Postprandial metabolite profiles associated with type 2 diabetes clearly stratify individuals with impaired fasting glucose.Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers i
P2860
Q31049198-F6CD3CF3-FBCB-4843-94FA-FD07099AE6C2Q31082889-E6B887FC-D77F-4481-8882-9C8DFB7D4FBBQ35767753-46C4B1FE-54EC-4D05-8222-A20CC20DBEF1Q36000943-2396764C-A507-49ED-A63C-E470D1557EBAQ36084114-41C94986-1F01-43C9-AF6E-634BE7D3E002Q36159065-B07CDDD5-AB26-420A-B509-AEED58991A42Q37023957-211A90F9-3079-4988-9782-D3487B696A78Q37676698-2603719A-5C45-4B69-A525-A721B617CB9AQ38617312-9E3EFDF3-AFDB-4FBF-9BE4-FCC2622438AEQ38657101-51943F25-31CE-4E4F-84E6-E81739A0E8ADQ38938307-0DE2AE39-CEE5-43A0-BD9D-644FA9B9A214Q38974645-63247E3F-D3E3-4C7E-8843-F4DAB035EB81Q39456476-C4E5F11A-24BF-4A37-B68A-5E7A0B3E8A0EQ40668617-5383EF5A-6439-41CE-85C4-185DCE048E43Q42236698-00BD2D97-72D3-460B-971B-D6AEF65B3E79Q47131166-15284299-BCF4-49C4-A492-046D29CB2B94Q52575994-F84F4383-CCF3-4410-9741-F60F595DC181Q59136772-82E1072B-99FF-4BA2-8D84-20514BD91D62
P2860
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metabolomics approach reveals ...... drugs on the human metabolism.
@ast
Metabolomics approach reveals ...... drugs on the human metabolism.
@en
type
label
Metabolomics approach reveals ...... drugs on the human metabolism.
@ast
Metabolomics approach reveals ...... drugs on the human metabolism.
@en
prefLabel
Metabolomics approach reveals ...... drugs on the human metabolism.
@ast
Metabolomics approach reveals ...... drugs on the human metabolism.
@en
P2093
P2860
P50
P1476
Metabolomics approach reveals ...... drugs on the human metabolism.
@en
P2093
Elisabeth Altmaier
Gisela Fobo
Jerzy Adamski
P2860
P2888
P304
P356
10.1007/S10654-014-9910-7
P50
P577
2014-05-10T00:00:00Z
P5875
P6179
1001801543